Cardiology Department ARRAZI Hospital, Mohammed VI University Hospital Marrakech Morocco
Case Study
World Journal of Advanced Research and Reviews, 2023, 20(02), 900-907
Article DOI: 10.30574/wjarr.2023.20.2.2093
Received on 03 September 2023; revised on 12 November 2023; accepted on 14 November 2023
Fabry disease (FD) is an inherited rare metabolic disease caused by a mutation in the GLA gene, encoding the lysosomal enzyme alpha-galactosidase A. The disorder is a systemic disease that manifests as cerebrovascular and cardiac disease, chronic renal failure, skin lesions, peripheral neuropathy, and other abnormalities. Arrhythmias, cardiac conduction disorders, and sudden deaths in Fabry diseases represent the main prognostic factors and are usually hard to manage. We describe here the case of a 56-year-old woman followed for Fabry disease with conductive and rhythmic cardiac involvement. Our case illustrates the pivotal role of critical clinical thinking in the management of rare but treatable hereditary cardiomyopathy like Fabry disease.
Fabry Disease; Arrhythmias; Conduction Disorders; Cardiovascular Implantable Electronic Devices; Anticoagulation.
Preview Article PDF
Mohsine NAAIM, Imane KATIF, Mohammed ZTATI, Mohammed ELJAMILI, Saloua EL KARIMI and Mustapaha EL HATTAOUI. Cardiovascular disorders in a patient with Fabry disease: A serious prognostic factor. World Journal of Advanced Research and Reviews, 2023, 20(2), 900-907. Article DOI: https://doi.org/10.30574/wjarr.2023.20.2.2093